Saturday 17 October 2026
Export PETV’s income statement to Excel — free account
PetVivo Holdings, Inc.
PETV Healthcare Medical Devices
PetVivo Holdings, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 million, up 0.80% from fiscal 2025. In the quarter to June 2026, revenue grew 13.5%, EPS grew 44.4% and free cash flow grew 40.1%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
0.75
0.01
+1.35%
Follow PETV
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
26.34 | 18.49 | 34.53 | 21.53 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(32.23) | (25.98) | (26.17) | (13.82) | |
P/B ratio |
23.04 | 9.62 | 11.38 | 7.26 | |
Price to Tangible BV |
114.73 | 21.23 | 41.38 | 18.83 | |
EV/Sales |
26.24 | 18.32 | 34.39 | 20.89 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(5.70) | (3.42) | (5.86) | (4.89) | |
EV/FCF |
(5.19) | (3.14) | (5.39) | (4.46) | |
Quick Ratio |
0.16 | 0.65 | 0.41 | 1.00 | |
Current Ratio |
0.72 | 1.24 | 1.40 | 2.00 | |
Net Debt/EBITDA |
0.08 | 0.07 | 0.08 | 0.87 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.25 | 0.18 | 0.30 | 0.33 | |
Operating CF/Net income |
0.56 | 0.26 | 0.63 | 0.70 | |
Capex/Depreciation |
(0.08) | 0.00 | 0.04 | (0.01) | |
Interest Coverage |
(321.76) | (1,974.53) | — | (2.19) | |
Research and Development Expense of Revenue |
69.14% | 192.42% | 112.90% | 86.19% | |
Selling, General and Administrative Expense of Revenue |
473.55% | 657.64% | 703.67% | 667.33% | |
Intangible Assets out of Total Assets |
0.40 | 0.34 | 0.56 | 0.49 | |
Share Based Compensation of Revenue |
136.43% | 187.99% | 198.71% | 230.60% | |
Graham Net Nets |
(0.01) | 0.02 | 0.01 | 0.03 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(40.48%) | (54.29%) | (33.33%) | (36.36%) | |
Free Cash Flow Yield |
(19.20%) | (31.53%) | (18.48%) | (21.75%) | |
Revenue per Share |
0.01 | 0.01 | 0.01 | 0.01 | |
Operating CF per Share |
(0.03) | (0.03) | (0.04) | (0.08) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.03) | (0.03) | (0.04) | (0.08) | |
Cash per Share |
0.00 | 0.01 | 0.01 | 0.03 | |
Shareholders Equity per Share |
0.04 | 0.07 | 0.10 | 0.15 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.04 | 0.07 | 0.10 | 0.15 | |
Free Cash Flow |
(0.98) | (0.81) | (1.46) | (2.20) | |
Working Capital |
(0.37) | 0.33 | 0.39 | 1.06 | |
Capital Expenditures |
(0.01) | 0.00 | 0.01 | (0.01) | |
Net Current Asset Value |
(0.37) | 0.33 | 0.39 | 1.03 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.00 | (0.02) | 0.03 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.05 | 2.58 | 0.36 | 0.14 | |
Average Payables |
0.60 | 0.68 | 0.71 | 0.57 | |
Average Inventory |
0.49 | 0.43 | 0.48 | 0.48 | |
Average Assets |
4.78 | 6.46 | 3.74 | 4.22 | |
Average Common Equity |
2.54 | 3.20 | 1.34 | 2.29 |
Columns are period end dates